The US Food and Drug Administration (FDA) has approved Gilead Sciences' injectable product, Yeztugo (lenacapavir), as a ...

THE United States Food and Drug Administration (FDA) on Wednesday approved Gilead Sciences' lenacapavir, a drug to be injected twice annually, for preventing HIV infection in adults and adolescents at ...

The approach employed by the research team could be used against other diseases—including COVID-19 and influenza.

The approval of lenacapavir for use as pre-exposure prophylaxis is a significant step in reducing the incidence of HIV across the globe, including in areas where the PURPOSE trials were conducted.

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

The breakthrough double injection won’t be cheap in the US, although scientists argue it could (and should) be.

FDA approves Yeztugo HIV prevention injection showing 96% efficacy in clinical trials, but $14,000 cost creates significant access barriers for patients.

Christian music artist Amy Grant performs to support PEPFAR, the global HIV/AIDS initiative facing budget cuts after saving ...

In two recent studies, this new shot reportedly nearly eliminated new infections in people at substantial risk of HIV.

The company said the Starship “experienced a major anomaly” at about 11 p.m. while on the test stand preparing for the tenth ...

Dozens of HIV experts at the Centers for Disease Control and Prevention received emails earlier in June revoking notices they ...

The U.S. Food and Drug Administration has approved a groundbreaking new HIV prevention drug that offers near-total protection ...